Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05827172
Status:
COMPLETED
Last Update Posted:
2023-04-24
First Post:
2023-04-11
Brief Title:
AF Ablation for HF With Reduced EF
Sponsor:
Shanghai Chest Hospital
Organization:
Shanghai Chest Hospital
Study Overview
Official Title:
Catheter Ablation vs Medical Treatment in Patients With HFrEF and Persistent AF CAEFR-AF
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open label multi-center randomized parallel control clinical trial to examining thethe clinical outcomes of AF ablation on HFrEF patients with persistent atrial fibrillation
Detailed Description:
This is an open label multi-center randomized parallel control clinical trial HFrEF patients with persistent atrial fibrillation are 11 randomized into the AF ablation group or the medical therapy rate or rhythm control group Markers of HFrEF severity including composite of death from any cause or worsening of heart failure that led to an unplanned overnight hospitalizationexercise hemodynamics natriuretic peptide levels and patient symptoms and other indicators are analyzed to demonstrate the role of AF ablation in comparing the effects of AF ablation vs usual medical therapy for HFrEF patients with persistent atrial fibrillation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None